In this special summer edition of Search, we take an in depth look at the work our scientists are doing in bringing new treatments to people with cancer, who are at the heart of everything we do. You ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test, a new study reports.

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.

Twenty years ago, a detailed draft and analysis of the human genome was completed. In this feature, Diana Cano Bordajandi looks at the lasting legacy of the Human Genome Project.

A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

Vortex Biosciences is expanding its footprint at The London Cancer Hub’s Innovation Gateway in support of its next phase of growth, having opened a new laboratory there earlier this year.